As of 2025-09-18, the Fair Value of Jazz Pharmaceuticals PLC (JAZZ) is -79.51 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 129.54 USD, the upside of Jazz Pharmaceuticals PLC is -161.38%.
With the market price of 129.54 USD and our fair value calculation, Jazz Pharmaceuticals PLC (JAZZ) is not a good investment. Investing in JAZZ stocks now will result in a potential loss of 161.38%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | 238.60 | -329.70 | -224.10 | 414.83 | 560.12 | 131.95 |
| YoY growth | -54.41% | -238.18% | 32.03% | 285.11% | 35.02% | 11.91% |
| Market Cap (mil) | 7,857.90 |
| P/E | |
| Forward P/E | 26.46x |
| EPS | -6.67 |
| Avg earnings growth rate | 11.91% |
| TTM earnings | -404.84 |